EDGAR Filing Documents for 0001683168-24-002440

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001683168-24-002440

Filing Date

2024-04-16

Accepted

2024-04-16 12:31:41

Documents

Period of Report

2024-02-29

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q FOR FEBRUARY 2024	cnbx_i10q-022924.htm iXBRL	10-Q	521272
2	CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER	cnbx_ex3101.htm	EX-31.1	10256
3	CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER	cnbx_ex3102.htm	EX-31.2	10187
4	CERTIFICATION	cnbx_ex3201.htm	EX-32.1	4845
5	CERTIFICATION	cnbx_ex3202.htm	EX-32.2	4741
6	GRAPHIC	image_001.jpg	GRAPHIC	9638
7	GRAPHIC	image_002.jpg	GRAPHIC	9680
8	GRAPHIC	image_003.jpg	GRAPHIC	8880
9	GRAPHIC	image_004.jpg	GRAPHIC	6081
10	GRAPHIC	image_005.jpg	GRAPHIC	16327
11	GRAPHIC	image_006.jpg	GRAPHIC	16097
12	GRAPHIC	image_007.jpg	GRAPHIC	20600
13	GRAPHIC	image_008.jpg	GRAPHIC	2874
14	GRAPHIC	image_009.jpg	GRAPHIC	20685
15	GRAPHIC	image_010.jpg	GRAPHIC	4305
16	GRAPHIC	image_011.jpg	GRAPHIC	10010
17	GRAPHIC	image_012.jpg	GRAPHIC	1208
	Complete submission text file	0001683168-24-002440.txt		2583406

Data Files

Seq	Description	Document	Type	Size
18	XBRL SCHEMA FILE	cnbx-20240229.xsd	EX-101.SCH	16849
19	XBRL CALCULATION FILE	cnbx-20240229_cal.xml	EX-101.CAL	27028
20	XBRL DEFINITION FILE	cnbx-20240229_def.xml	EX-101.DEF	39086
21	XBRL LABEL FILE	cnbx-20240229_lab.xml	EX-101.LAB	179046
22	XBRL PRESENTATION FILE	cnbx-20240229_pre.xml	EX-101.PRE	139801
56	EXTRACTED XBRL INSTANCE DOCUMENT	cnbx_i10q-022924_htm.xml	XML	169304

Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814

Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429

CNBX Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)